
Advancements in targeted therapies, including immune checkpoint inhibitors, antibody-drug conjugates, and drugs targeting replication stress, are transforming the treatment landscape for patients with advanced or recurrent endometrial cancer.


coremsg

Drs Ursula A. Matulonis and Joyce F. Liu discuss new therapeutics for patients with endometrial cancer, including ADCs, immunotherapy, and drugs targeting replication stress.

Episode 3: Targeted Therapy in Endometrial Cancer

exploring-targeted-therapies-for-advancing-endometrial-cancer-treatment


Exploring Targeted Therapies for Advancing Endometrial Cancer Treatment
